Investor Notes - Phillip Securities (HK) Ltd
Past Investor Notes *Advertisement*
Phillip Home Send to Friends Free Subscription Give Comments 中文版
12 Oct, 2017 (Thursday)


JUMPCAN(600566)
Analysis:
Jumpcan Pharm recorded revenue and net profit of RMB2.81bn/580mn representing 19.39%/32% YoY growth. Although pricing pressure is relatively large because of tender and second bargaining of hospitals, the pricing power of Jumpcan remains relatively robust due to the exclusive products and drug forms (i.e. Pudilan, chiqiao granule for pediatric heat clearance). Furthermore, the company actively boost network in OTC market and build a professional OTC sales team, and pharm store sales continues to rise. Jumpcan invests to build Shanghai R & D Institute in order to strengthen R&D capability to lay the foundation for long-term development.
Strategy:
Buy-in Price: CNY39.09, Target Price: CNY48.00, Cut Loss Price: CNY34.50


Yutong (600066.CH) - The NEV bus industry has gradually warmed up, with a high probability of explosive growth for 2017Q4 result

- 2017H1 net profit down by 30% in due to the industry policies interfered

- The gross margin rose by 0.1 ppts, and the market share expanded against trend

- The NEV industry has gradually warmed up, with a high probability of explosive growth in 2017Q4

Investment Thesis

We forecast that the company's EPS in 2017/2018 will be RMB1.87 and RMB2.13. Considering the leading position and its continued technological advancement in new energy vehicles to drive down costs and broaden its market, our target price is set unchanged at RMB29. It is equivalent to a prospective 2017/2018 PE of 15.5x and 13.6x respectively. We give “Accumulate” rating. (Closing price as at 10 Oct 2017)

Quick-frozen industry interfered by policies and decrease in net profit of the company by 30% in H1

Yutong Bus recorded a total revenue of RMB9.31 billion in H1 2017, down by 30% YoY; the net profit attributable to the parent company stood at RMB810 million, down by 34.8% YoY. Basic EPS was RMB0.36, compared with RMB0.56 in the same period last year. EPS in Q1 and Q2 were RMB0.14 and RMB0.22, respectively.

Influenced by multiple adjustments of subsidies for new energy passenger vehicles, including investigations on subsidy defrauding, state subsidy fall-off and local subsidy lagging behind, China's new energy passenger vehicles industry has been quick-frozen in the first half of the year. Sales of new energy passenger vehicles have basically stagnated. The main growth engine of Yutong Bus has been sharply stalled in recent years, with semi-annual cumulative sales down by 28% YoY to 2.18 million units. According to the Ministry of Industry and Information Technology, the number of new energy passenger vehicles produced by Yutong Bus in H1 was down by nearly 60% YoY.

The gross margin rose by 0.1 ppts, and the market share expanded against trend

The sales volumes of large, medium and light passenger vehicles of Yutong Bus fell by 7.5%, 40% and 15% YoY to 8,751, 9,947, and 3,136 units, respectively. Due to the increase in the proportion of large passenger vehicles, the gross margin of the Company was 24.9% in the first half of the year, up by 0.1 ppts YoY, while the gross margins in 1Q and 2Q were 24% and 25.6%, respectively. The Company's export sector has performed well, with the volume of exported passenger vehicles up by 17% YoY to 4,356 units.

The adjustment of state subsidies for new energy passenger vehicles has raised the industry threshold, and accelerated the industry clearing. The market concentration of the industry leaders such as Yutong Bus has been significantly improved. The Company's share of vehicle models in the range of 10 meters above, 8 to 10 meters and 6 to 8 meters reached 18.5%, 40% and 12%, respectively. The market share is up by 1.7, 9.3 and 9.5 ppts, respectively, from Year 2016.

The period cost rate rose by 2.1 ppts, mainly due to the rigidity of administration expenses and the delayed grant of state subsidies. During the reporting period, the Company spent RMB505 million on R&D, up by 11% YoY, mainly for such cutting-edge technology as development and optimization of high-end models, new energy buses, lightweight technology and intelligent driving and fuel cells.

The new energy passenger vehicle industry has gradually warmed up, with a high probability of explosive growth in the fourth quarter

With the end of the policy vacuum, the new energy passenger vehicle industry has gradually warmed up. The sales volume of Yutong Bus started to soar from June. In the new edition of the subsidy catalogue, Yutong Bus has obtained subsidy eligibility for 91 new energy passenger vehicles and 3 new energy special vehicles. The bidding for new energy vehicles for all the public transport companies is being fully restarted. We anticipate Yutong Bus will usher in a period of explosive growth of new energy vehicle orders in the fourth quarter.

Financials

Click Here for PDF format...




Recommendation on 12-10-2017
RecommendationAccumulate
Price on Recommendation Date$ 24.850
Suggested purchase priceN/A
Target Price$ 29.000
Writer Info
Zhang Jing
(Research Analyst)
Tel: (+86 21 51699400-103)
Email:
zhangjing@phillip.com.cn

Local Index
       Index    Change   Change%

World Index
       Index    Change   Change%
  

A-H spread
Stock Code H share
Price
A share
Price
H share
discount


Oversea Research Reports


Investment Service Centre



Enquiry : 2277 6666 OR investornotes@phillip.com.hk
If you cannot read this e-mail in the proper format, please click here to view the web version.

Phillip Research - Hong Kong 輝立研究部 – 香港及中國
Company Stock Code Last Update Suggestion Target Price Price on Recom
Information Techology Research Department N/A+852 2277 6527research@phillip.com.hk
Karrie International105015/09/2017No Rating1.24
Goldpac Group331527/03/2017Buy32.4
Transportation and Automobiles Zhang Jing (86) 2151699200-103zhangjing@phillip.com.cn
Yutong60006612/10/2017Accumulate29.00 0.000
SIA60000904/10/2017Accumulate44.3537.98
Insurance Research Department (86) 21 51699400-110research@phillip.com.cn
Media & Publishing Research Department (+ 86 21 51699400-107)research@phillip.com.cn
Wisdom Sports Group166111/07/2016Buy3.32.18
NetDragon77716/06/2016Buy28.422.9
Pharmaceutical Fan Guohe  (+ 86 21 51699400-110)fanguohe@phillip.com.cn
CSPC Pharmaceutical109306/10/2017Accumulate14.4513.54
Tasly Pharmaceutical Group600535.CH24/08/2017Accumulate43.838.52
Industrial Goods Ocean Pan +852 2277 6515oceanpan@phillip.com.hk
DONGJIANG ENV89511/10/2017Buy1411.46
DONGJIANG ENV89511/08/2017Buy13.810.64
Health & Personal Care Fan Guohe  (+ 86 21 51699400-110)fanguohe@phillip.com.cn
HEC Pharm155802/06/2017Buy22.2417.08
Luye Pharma218622/03/2017Buy6.34.95
New Energy Wang Yannan 86 21 51699400-107wangyannan@phillip.com.cn
HN RENEWABLES95827/02/2017Buy3.52.72
CONCORD NE18224/10/2016Buy0.60.39
Food, Beverage and Retail Research Department (86) 21 51699400-110research@phillip.com.cn
L`OCCITANE97322/05/2017Accumulate1715.3
L`OCCITANE97319/05/2017Accumulate1715.3
Textiles & Clothing Ocean Pan +852 2277 6515oceanpan@phillip.com.hk
JNBY330613/04/2017Accumulate6.65.95
CECEP COSTIN New Materials Group222818/10/2013Buy5.64.23
Telecommunications Fan Guohe + (86) 21 51699400-110fanguohe@phillip.com.cn
Chinasoft International35409/08/2017Buy5.884.39
Chinasoft International Ltd35410/04/2017Buy5.84.61
Mainland Property John Wong +852 2277 6527johnycwong@phillip.com.hk
KWG Property181314/09/2017Neutral8.48.47
Logan Property338021/08/2017Buy8.87.28
Basic Materials Ocean Pan +852 2277 6515oceanpan@phillip.com.hk
Yip's Chemical40815/06/2017No Rating3.29
ND Paper268905/04/2017Accumulate9.58.35
Utilities Research Department +852 2277 6527research@phillip.com.hk
Dynagreen133026/09/2017Buy6.44.32
Grandblue ENV60032319/09/2017Accumulate17.414.83
Properties John Wong +852 2277 6527johnycwong@phillip.com.hk
Kerry Properties68310/10/2017Buy36.733.8
Kerry Properties68309/10/2017Buy36.733.8
Software & Service Research Department (86) 21 51699400-110research@phillip.com.cn
IGG800221/11/2014Accumulate3.953.44
HC INTERNATIONAL228006/11/2014Buy14.928.8
Hotels and Entertainment John Wong (+ 852 2277 6527)johnycwong@phillip.com.hk
Hongkong & Shanghai Hotels4516/08/2017Neutral12.513.18
Hongkong & Shanghai Hotels4515/08/2017Neutral12.513.18

Information contained herein is based on sources that Phillip Securities (Hong Kong) Limited and/or its affiliates ( the “Group”) believe to be accurate. The Group does not bear responsibility for any loss occasioned by reliance placed upon the contents hereof. The Group (or its employees) may have interests in relevant investment products. For details of different products’ risks, please view the Risk Disclosures Statement on http://www.phillip.com.hk.

If you DO NOT wish to receive further marketing emails from us, please click HERE to opt-out.

版權所有, 翻印必究。

Copyright(C) 2017 Phillip Securities (HK) Ltd. All Rights Reserved.